Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology
- 1 June 2011
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 121 (3), 505-509
- https://doi.org/10.1016/j.ygyno.2011.02.033
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany – Experience over 3 yearsJournal of Clinical Virology, 2009
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized SettingJNCI Journal of the National Cancer Institute, 2009
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialThe Lancet Oncology, 2009
- Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialThe Lancet Oncology, 2008
- Human Papillomavirus mRNA and p16 Detection as Biomarkers for the Improved Diagnosis of Cervical NeoplasiaCancer Epidemiology, Biomarkers & Prevention, 2008
- Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialThe Lancet, 2007
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerThe New England Journal of Medicine, 2007
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patientsBritish Journal of Cancer, 2003